We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.67B
AUM Growth
+$2.26B
Cap. Flow
+$1.95B
Cap. Flow %
20.18%
Top 10 Hldgs %
21.78%
Holding
2,843
New
810
Increased
656
Reduced
567
Closed
731

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$257M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$254M
3
MSFT icon
Microsoft
MSFT
+$247M
4
AER icon
AerCap
AER
+$77.8M
5
ON icon
ON Semiconductor
ON
+$61.6M

Sector Composition

Rank Sector Weight
1 Technology 15.23%
2 Consumer Discretionary 11.75%
3 Industrials 11.23%
4 Financials 8.63%
5 Healthcare 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPTU
2151
Optimum Communications Inc
OPTU
$323M
-231,579
Closed -$4.8M
AVA icon
2152
Avista
AVA
$3.15B
-7,937
Closed -$310K
AVD icon
2153
American Vanguard Corp
AVD
$67.9M
-16,321
Closed -$246K
AVXL icon
2154
Anavex Life Sciences
AVXL
$300M
-35,342
Closed -$634K
AVY icon
2155
Avery Dennison
AVY
$13.9B
-7,618
Closed -$1.58M
DCH
2156
Dauch Corp
DCH
$1.63B
-205,518
Closed -$1.81M
AXTI icon
2157
AXT Inc
AXTI
$4.64B
-23,620
Closed -$197K
AYTU icon
2158
AYTU BioPharma
AYTU
$25.4M
-800
Closed -$46K
BABA icon
2159
CALL
Alibaba
BABA
$286B
-913,000
Closed -$135M
BABA icon
2160
PUT
Alibaba
BABA
$286B
-786,000
Closed -$116M
BAH icon
2161
Booz Allen Hamilton
BAH
$9.27B
-15,670
Closed -$1.24M
BAND
2162
Bandwidth Inc
BAND
$1.53B
-26,352
Closed -$2.38M
BANF icon
2163
BancFirst
BANF
$3.79B
-14,528
Closed -$873K
BATRA icon
2164
Atlanta Braves Holdings Series A
BATRA
$3.64B
-797
Closed -$21K
BBAR icon
2165
BBVA Argentina
BBAR
$2.87B
-15,542
Closed -$60K
BBD icon
2166
Banco Bradesco
BBD
$33.9B
-65,503
Closed -$228K
BBIO icon
2167
BridgeBio Pharma
BBIO
$15.9B
-26,393
Closed -$1.24M
BC icon
2168
Brunswick
BC
$5.24B
-37,830
Closed -$3.6M
BCS icon
2169
Barclays
BCS
$90.2B
-51,925
Closed -$536K
BDTX icon
2170
Black Diamond Therapeutics
BDTX
$127M
-21,432
Closed -$181K
BEKE icon
2171
KE Holdings
BEKE
$19.6B
-11,122
Closed -$203K
BEN icon
2172
Franklin Templeton
BEN
$17.4B
-71,562
Closed -$2.13M
BHE icon
2173
Benchmark Electronics
BHE
$2.61B
-11,659
Closed -$311K
BHR
2174
Braemar Hotels & Resorts
BHR
$142M
-10,744
Closed -$52K
BILL icon
2175
CALL
BILL Holdings
BILL
$4.76B
-30,000
Closed -$8.04M

Similar funds

Michael Gelband's Q4 2021 Portfolio in Review

As of Q4 2021, Michael Gelband held 2,843 positions worth $9.67B, up 30% from $7.41B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Michael Gelband deployed $1.95B of net new capital in Q4 2021, opening 810 new positions and adding to 656 existing holdings. Its largest new stake was Amazon: 1,500,500 shares worth $250M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $76.2M trimmed.

  • Michael Gelband's largest Q4 2021 buy was Amazon: 1,500,500 shares worth $250M.
  • Michael Gelband added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $254M increase.
  • Michael Gelband's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $76.2M.
  • Michael Gelband fully exited Diamondback Energy in Q4 2021, selling an estimated $44.8M.
  • Michael Gelband's ten largest holdings make up 22% of its $9.67B portfolio in Q4 2021.
  • Michael Gelband opened 810 new positions and closed 731 in Q4 2021.
  • Michael Gelband's portfolio value rose 30% quarter-over-quarter to $9.67B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.